We have a number of long-standing projects in India, which we run in conjunction with the state authorities to address existing healthcare needs and emerging public health concerns.
We also run mobile clinics in remote areas of the country, where even preventable, treatable conditions such as malaria can assume life-threatening proportions.
We provide medical and psychosocial care for people living with HIV and drug-resistant tuberculosis in and around Mumbai, a city of 22 million people, around 50,000 of whom have TB, and 4,000 are infected with drug-resistant strains of the disease. We also have a team providing specialised care for TB, HIV and hepatitis C in Manipur, and in 2017 we set up a dedicated hepatitis C clinic in Meerut city. Kala azar is also endemic and particularly prevalent in Bihar, where our focus is on addressing kala azar-HIV co-infection.
A third of the world’s severely acutely malnourished children live in India, according to joint estimates by UNICEF, the WHO and the World Bank Group. Since 2009, our teams have treated over 17,000 children with severe acute malnutrition in India in the states of Bihar and Jharkhand, using an innovative community-based model.
In the capital, Delhi, we provide medical and psychological care to victims of domestic and sexual violence, and raise awareness about the importance of seeking timely medical and psychological care. We work with community-based organisations, police, government protection agencies and the health ministry to highlight the clinic’s services and create an efficient referral system. We also engage the community in discussions on domestic violence, sexual assault and child abuse.
Since 2001 we have been offering counselling in Jammu and Kashmir, where years of conflict have taken a toll on people’s mental health. Our work includes raising awareness of the support available, reducing the stigma associated with mental health, and emphasising the importance of seeking assistance.
We have been investigating antibiotic resistance in Asansol district since 2015, where we also run community outreach initiatives promoting the importance of good hygiene practices, and the rational prescription and consumption of antibiotics.
Have you heard of kala azar?
Kala azar is a neglected but potentially fatal tropical disease. India accounts for 30 per cent of cases worldwide.
This short animation explains what kala azar is, how it relates to HIV, and what we are doing in response.
Since 80 per cent of India's kala azar cases are reported in Bihar, we set up a programme there in 2007.
People living with HIV are particularly vulnerable to kala azar, so since 2016 we have been focusing on treating patients co-infected with the two diseases, in partnership with the Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Bihar.
Access Campaign: New threat against affordable medicines in trade negotiations with India and ASEAN
At EU-India Summit, India must defend its pharmacy of the developing world
MSF launches challenge to Pfizer’s patent on the pneumonia vaccine in India to increase access to more affordable versions
Patent challenge hearing on Gilead hepatitis C drug sofosbuvir starts in India
At African Union – India meeting, leaders should work together to protect access to affordable medicines
MSF urges India to protect affordable medicines for millions
Why MSF needs India to remain open for business
Gallery: Chhattisgarh, India: Walking that extra mile
Access Campaign: MSF launches global campaign urging India to protect access to affordable medicines
MSF calls for community management of acute malnutrition after new evidence shows high cure rates
Indian generic companies should reject Gilead’s controversial hepatitis C ‘Anti-Diversion’ programme
Increased access to diagnosis and treatment of HIV-VL co-infection is imperative for eliminating kala azar
AISF Building, 1st & 2nd Floor
Amar Colony, Lajpat Nagar -IV